Nagio Takigawa
Department Kawasaki Medical School Kawasaki Medical School, Department of General Internal Medicine 4, Position Professor |
|
Language | English |
Title | Phase I/II trial of weekly nab-paclitaxel as 2nd or 3rd line treatment in NSCLC without driver mutations (OLCSG1303) |
Conference | ESMO 2017 Congress |
Conference Type | International society and overseas society |
Presentation Type | Poster notice |
Publisher and common publisher | ◎Ninomiya T, Hotta K, Ohashi K, Kubo T, Harada D, Kozuki T, Nogami N, Oze I, Hosokawa S, Bessho A, Yoshioka H, Kudo K, Kuyama S, Harita S, Takata I, Fujimoto N, Moritaka T, Ichikawa H, Takigawa N, Kiura K |
Date | 2017/09/09 |
Venue (city and name of the country) |
Spain |